Organizing committee invites all participants from all over the world to attend “16th World Congress on Infection Prevention and Control’’ during September 16-17, 2020 in Dubai, UAE.

Infection Prevention and Control is a global overview with the Theme: “Exploring and revealing new Innovative research in Infectious Diseases, Prevention and Control” is designed for professionals at all to create awareness on the current needs & growth of Infectious Diseases, Infection preventions, Infection Control. Also, to bring together bright minds to give talks that are idea-focused and on a wide range of subjects, to foster learning, inspiration and wonder – and provoke conversations that matter. The strength of the Conference is that the participants tend to include all phases of the value chain as well as individuals from a wide variety of sector and countries.

Why to attend???

•  Build your professional network.
•  Hear about the latest research.
•  Improve your presentation and communication skills.
•  Get response on an early version of your latest work.
•  Acquire beyond your field or interest.
•  Get opportunity to people to meet you.
•  Know the strengths and weakness of your conferences.
•  Easier to solve the problems and struggles which you go through at work.

Target Audience:

• Scientists
• Young  research  fellows
• Research Scholars
• Students
• Infectious Diseases Experts
• Pathologists
• Infectious Diseases Specialists
• Pharmacists
• Epidemiologists
• Health Care Professionals
• Microbiologists
• Bacteriologists
• Virologists
• Parasitologists
• Mycologists
• Infection Prevention and Infection Control Specialists
• Infection Prevention Organizations & Companies
• Immunologists

Market Growth of Infection Prevention:

Infection Prevention in Middle East and Africa Infectious Disease Therapeutics Market accounts for USD 8.42 Billion in 2018 and assessed to achieve 12.29 USD Billion by the end of 2023 with a developing potential of 7.877 %. The Middle East and Africa Infectious disease therapeutics market are categorized based on Mode of treatment into Drugs and Vaccines. The drugs are further segmented into oral administration, topical, injections and others.  Based on the target organism the market is categorized into antibacterial, antifungal, antiviral, antiparasitic and others. Based on infection type the market is categorized into Bacterial, viral, fungal, parasite and others. Based on distribution channels the market is categorized into hospitals, clinics and others. Based on Geography, the Middle East and Africa Infectious disease therapeutics market is analysed under various regions namely the Middle East and Africa. The global infectious disease therapeutics market size was valued at USD 46.88 billion in 2016 and is projected to grow at a CAGR of 6.6% during the forecast period.

The global market for infectious disease treatments totaled $64.8 billion in 2017. The market should total $99 billion by 2022, growing at a compound annual growth rate (CAGR) of 8.9% from 2017 to 2022.

The global infectious disease diagnostics market is expected to reach USD 25.43 billion by 2027 from USD 15.57 billion in 2018, at a CAGR of 5.6%. The increasing global prevalence of infectious diseases, the shift in focus from centralized laboratories to decentralized point-of-care testing, and growth in funding for research on diagnostics infections are some the factors driving the growth of this market.

Best Regards         
Mary Grace | Program Director        
Conference Short Name: Infection Prevention 2020         
Contact Number: +44 7426050685 
Email: infectionprevention@brainstormingmeetings.com
Website: https://infectionprevention.insightconferences.com/